AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 144 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $108,000 | -68.0% | 150,335 | +0.5% | 0.00% | – |
| Q4 2021 | $338,000 | -21.6% | 149,635 | 0.0% | 0.00% | – |
| Q3 2021 | $431,000 | -24.0% | 149,635 | 0.0% | 0.00% | – |
| Q2 2021 | $567,000 | +150.9% | 149,635 | +123.9% | 0.00% | – |
| Q1 2021 | $226,000 | +20.9% | 66,835 | 0.0% | 0.00% | – |
| Q4 2020 | $187,000 | -57.2% | 66,835 | -61.6% | 0.00% | – |
| Q3 2020 | $437,000 | -81.9% | 174,006 | -2.4% | 0.00% | -100.0% |
| Q2 2020 | $2,421,000 | +160.0% | 178,306 | +45.2% | 0.00% | 0.0% |
| Q1 2020 | $931,000 | +20.0% | 122,819 | 0.0% | 0.00% | – |
| Q4 2019 | $776,000 | +61.3% | 122,819 | 0.0% | 0.00% | – |
| Q3 2019 | $481,000 | -19.0% | 122,819 | 0.0% | 0.00% | – |
| Q2 2019 | $594,000 | -36.3% | 122,819 | +7.9% | 0.00% | -100.0% |
| Q1 2019 | $932,000 | +54.0% | 113,819 | +4.0% | 0.00% | – |
| Q4 2018 | $605,000 | +32.4% | 109,420 | +111.2% | 0.00% | – |
| Q3 2018 | $457,000 | -11.6% | 51,800 | 0.0% | 0.00% | – |
| Q2 2018 | $517,000 | +25.5% | 51,800 | +19.9% | 0.00% | – |
| Q1 2018 | $412,000 | -35.8% | 43,200 | 0.0% | 0.00% | – |
| Q4 2017 | $642,000 | -24.5% | 43,200 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $850,000 | +36.9% | 43,200 | 0.0% | 0.00% | – |
| Q2 2017 | $621,000 | +300.6% | 43,200 | +157.1% | 0.00% | – |
| Q1 2017 | $155,000 | -11.4% | 16,800 | 0.0% | 0.00% | – |
| Q4 2016 | $175,000 | +26.8% | 16,800 | +10.5% | 0.00% | – |
| Q3 2016 | $138,000 | +31.4% | 15,200 | +7.8% | 0.00% | – |
| Q2 2016 | $105,000 | +303.8% | 14,100 | +513.0% | 0.00% | – |
| Q1 2015 | $26,000 | -3.7% | 2,300 | 0.0% | 0.00% | – |
| Q4 2014 | $27,000 | -66.2% | 2,300 | -36.1% | 0.00% | – |
| Q3 2014 | $80,000 | -20.0% | 3,600 | 0.0% | 0.00% | – |
| Q2 2014 | $100,000 | – | 3,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |